Marc O. Johnson
Cambridge Scientific (United States)(US)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Immune Cell Function and Interaction, Metabolomics and Mass Spectrometry Studies, Immune cells in cancer, T-cell and B-cell Immunology
Most-Cited Works
- → Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism(2018)680 cited
- → Amino Acids Rather than Glucose Account for the Majority of Cell Mass in Proliferating Mammalian Cells(2016)646 cited
- → Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression(2016)509 cited
- → Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models(2018)474 cited
- → Sniffing Behavior of Mice during Performance in Odor-Guided Tasks(2008)243 cited
- → A Predictive Model for Selective Targeting of the Warburg Effect through GAPDH Inhibition with a Natural Product(2017)197 cited
- → Nutrients and the microenvironment to feed a T cell army(2016)66 cited
- → Interaction of 14-3-3 Protein with Regulator of G Protein Signaling 7 Is Dynamically Regulated by Tumor Necrosis Factor-α(2002)60 cited
- → The PGI2 Analog Cicaprost Inhibits IL-33–Induced Th2 Responses, IL-2 Production, and CD25 Expression in Mouse CD4+ T Cells(2018)21 cited
- → Abstract 6639: SRF617, a potent enzymatic inhibitor of CD39, demonstrates single-agent activity and cooperates with various cancer therapies in both solid tumor and hematologic malignancies(2020)7 cited